1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Acid beta-Glucosidase Deficiency in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Radin, NS | 1 |
Bieberich, E; Freischütz, B; Suzuki, M; Yu, RK | 1 |
1 review(s) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Acid beta-Glucosidase Deficiency
Article | Year |
---|---|
Treatment of Gaucher disease with an enzyme inhibitor.
Topics: Animals; Cells, Cultured; Enzyme Inhibitors; Fishes; Gaucher Disease; Glucosylceramidase; Humans; Mice; Morpholines; Rats | 1996 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Acid beta-Glucosidase Deficiency
Article | Year |
---|---|
Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
Topics: 1-Deoxynojirimycin; Animals; Apoptosis; Brain Neoplasms; Cell Death; Cell Division; Ceramides; Enzyme Inhibitors; Gaucher Disease; Glucosylceramides; Glucosyltransferases; Glycolipids; Mice; Morpholines; Neuroblastoma; Rats; Tumor Cells, Cultured | 1999 |